Condensed Consolidated Statements of Convertible Preferred Stock and Changes In Stockholders' Equity (Deficit) - USD ($) $ in Thousands		Total	Convertible Preferred Stock	Preferred Stock Convertible Preferred Stock	Common Stock	Additional Paid-in Capital	Notes Receivable from Related Parties	Accumulated Deficit	Accumulated Comprehensive Income
Balance, before retroactive conversion		$ (49,896)		$ 46,370	$ 2	$ 5,383	$ (103)	$ (55,178)
Retroactive application					$ (1)	1
Retroactive application, shares	[1]			(126,942,949)	(15,778,049)
Balance, before retroactive conversion, shares	[1]			165,578,120	20,580,109
Beginning balance at Dec. 31, 2021		(49,896)		$ 46,370	$ 1	5,384	(103)	(55,178)
Beginning balance, shares at Dec. 31, 2021	[1]			38,635,171	4,802,060
Issuance of common stock upon exercise of stock options		17				17
Issuance of common stock upon exercise of stock options, shares	[1]				26,797
Stock-based compensation expense		26				26
Net income loss		(5,697)						(5,697)
Ending balance, shares at Mar. 31, 2022	[1]			38,635,171	4,828,857
Ending balance at Mar. 31, 2022		(55,550)		$ 46,370	$ 1	5,427	(103)	(60,875)
Beginning balance at Dec. 31, 2021		(49,896)		$ 46,370	$ 1	5,384	(103)	(55,178)
Beginning balance, shares at Dec. 31, 2021	[1]			38,635,171	4,802,060
Net income loss		(5,519)
Ending balance, shares at Jun. 30, 2022	[1]			42,810,492	4,838,707
Ending balance at Jun. 30, 2022		(55,340)		$ 68,082	$ 1	5,459	(103)	(60,697)
Beginning balance at Mar. 31, 2022		(55,550)		$ 46,370	$ 1	5,427	(103)	(60,875)
Beginning balance, shares at Mar. 31, 2022	[1]			38,635,171	4,828,857
Issuance of common stock upon exercise of stock options		6				6
Issuance of common stock upon exercise of stock options, shares	[1]				9,850
Stock-based compensation expense		26				26
Proceeds from sale of Series E, net of issuance costs				$ 21,712
Proceeds from sale of Series E, net of issuance costs, shares	[1]			4,175,321
Net income loss		178						178
Ending balance, shares at Jun. 30, 2022	[1]			42,810,492	4,838,707
Ending balance at Jun. 30, 2022		(55,340)		$ 68,082	$ 1	5,459	$ (103)	(60,697)
Balance before retroactive application of recapitalization		(55,692)		$ 87,140	2	6,521		(62,215)
Retroactive application					$ (1)	1
Retroactive application, shares	[1]		(152,677,720)		(17,972,432)
Balance before retroactive application of recapitalization, shares	[1]			199,145,285	23,442,353
Beginning balance at Dec. 31, 2022		(55,692)		$ 87,140	$ 1	6,522		(62,215)
Beginning balance, shares at Dec. 31, 2022	[1]			46,467,565	5,469,921
Issuance of common stock upon exercise of stock options		92				92
Issuance of common stock upon exercise of stock options, shares	[1]				140,545
Stock-based compensation expense		366				366
Issuance of common stock in connection with the acquisition of fSight, shares	[1]				1,306,385
Issuance of common stock in connection with the acquisition of fSight		10,077				10,077
Unrealized gain (loss) resulting from change in fair value of marketable securities		14							$ 14
Stock Issued During Period, Shares, Acquisitions	[1]				1,306,385
Net income loss		6,910						6,910
Ending balance, shares at Mar. 31, 2023	[1]			46,467,565	6,916,851
Ending balance at Mar. 31, 2023		(38,233)		$ 87,140	$ 1	17,057		(55,305)	14
Beginning balance at Dec. 31, 2022		$ (55,692)		$ 87,140	$ 1	6,522		(62,215)
Beginning balance, shares at Dec. 31, 2022	[1]			46,467,565	5,469,921
Issuance of common stock upon exercise of stock options, shares		151,338
Issuance of preferred stock upon exercise of preferred warrants		$ 2,008
Conversion of convertible preferred stock into common stock in connection with the Business Combination		87,140	$ (87,140)		$ 5	87,135
Conversion of convertible preferred stock into common stock in connection with the Business Combination, shares	[1]		(47,918,992)		47,918,992
Net income loss		(15,266)
Ending balance, shares at Jun. 30, 2023	[1]				58,144,543
Ending balance at Jun. 30, 2023		30,434			$ 6	120,671		(90,062)	(181)
Beginning balance at Mar. 31, 2023		(38,233)		$ 87,140	$ 1	17,057		(55,305)	14
Beginning balance, shares at Mar. 31, 2023	[1]			46,467,565	6,916,851
Issuance of common stock upon exercise of stock options		14				14
Issuance of common stock upon exercise of stock options, shares	[1]				10,784
Forfeitures of restricted stock and restricted stock surrendered in lieu of withholding taxes		(91)				(91)
Forfeitures of restricted stock and restricted stock surrendered in lieu of withholding taxes, shares	[1]				(11,832)
Stock-based compensation expense		497				497
Unrealized gain (loss) resulting from change in fair value of marketable securities		(195)							(195)
Convertible preferred stock dividends, shares	[1]			1,258,055
Convertible preferred stock dividends						12,581		(12,581)
Issuance of preferred stock upon exercise of preferred warrants		2,008				2,008
Issuance of preferred stock upon exercise of preferred warrants, shares	[1]			193,372
Issuance of common stock upon exercise of common warrants, shares	[1]				1,491,229
Purchase price adjustment in connection with the fSight acquisition		897				897
Issuance of common stock upon Business Combination, shares	[1]				1,818,519
Issuance of common stock upon Business Combination, value		573				573
Net income loss		(22,176)							(22,176)
Ending balance, shares at Jun. 30, 2023	[1]				58,144,543
Ending balance at Jun. 30, 2023		$ 30,434			$ 6	$ 120,671		$ (90,062)	$ (181)

[1] The shares of the Company’s common and redeemable convertible preferred stock prior to the Business Combination (as defined in Note 1) have been retroactively restated to reflect the exchange ratio of approximately 0.233335 established in the Business Combination as described in Note 3.